News Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 17:20:42 20/05/2026 BST			5-day change	1st Jan Change
448.00 ^USD	+0.04%		-0.50%	-23.41%

03:14pm	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
02:25pm	Thermo Fisher Scientific highlights industry leadership, growth outlook and long-term value creation at 2026 Investor Day	RE

All News

Mentions Relevance

05:20pm	Thermo Fisher Scientific Inc. - Analyst/Investor Day
02:25pm	Thermo Fisher Scientific highlights industry leadership, growth outlook and long-term value creation at 2026 Investor Day	RE
02:06pm	Thermo Fisher Expects 7% Annual Organic Revenue Growth Over Long Term	DJ
01:49pm	Thermo Fisher Scientific : 2026 Investor Day	PU
01:31pm	Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day	BU
05-18	Thermo Fisher Scientific Expands Bioanalytical Capabilities With New Laboratory In Gothenburg Sweden	CI
05-15	Thermo Fisher Likely to Benefit From End-Market Recovery, but Structural Risks Remain, RBC Says	MT
05-11	Nalgene Outdoor Introduces Fresh Flow Straw Bottle	CI
05-11	Thermo Fisher Scientific : Additional Soliciting Materials	PU
05-04	Thermo Fisher Scientific Inc. Introduces Gibco CTS DynaXS Single Use Bioreactor	CI
05-01	Argus Adjusts Price Target on Thermo Fisher Scientific to $560 From $610	MT
04-30	Argus Cuts Price Target on Thermo Fisher Scientific to $560 From $610	MT
04-28	Thermo Fisher Scientific opens U.S. flagship bioprocess design center to accelerate the delivery of life-changing therapies	RE
04-28	Thermo Fisher Scientific Expands Plainville Facility with Flagship Bioprocess Design Center	CI
04-28	Thermo Fisher Scientific to Host Investor Day	BU
04-27	Morgan Stanley Lowers Price Target on Thermo Fisher Scientific to $620 From $670, Keeps Overweight Rating	MT
04-27	Astorg III, FCPR, managed by Astorg Asset Management S A.R.L. signed a definitive agreement to acquire Global Microbiology Business from Thermo Fisher Scientific Inc. for approximately $1.1 billion.	CI
04-27	Thermo Fisher to Sell Microbiology Business to Astorg for About $1.075 Billion	DJ
04-27	Thermo Fisher Scientific signs agreement to sell its microbiology business to Astorg	RE
04-27	Thermo Fisher Scientific to Sell Microbiology Business to Astorg for $1.08 Billion	MT
04-27	Thermo Fisher to sell microbiology business to PE firm Astorg for over $1 billion	RE
04-27	Thermo Fisher Scientific to Sell Microbiology Business to Astorg for $1.08 Billion	MT
04-27	Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion	RE
04-27	Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg	BU
04-27	Morgan Stanley Lowers Price Target on Thermo Fisher Scientific to $620 From $670, Keeps Overweight Rating	MT